Drug Induced Pneumonitis Secondary to Treatment with ParitaprevirRitonavirOmbitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction
المؤلفون المشاركون
Wu, Shih Yea Sylvia
Faire, Bridget
Gane, Edward
المصدر
العدد
المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-5، 5ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2017-03-20
دولة النشر
مصر
عدد الصفحات
5
التخصصات الرئيسية
الملخص EN
VIEKIRA PAK (ritonavir-boosted paritaprevir/ombitasvir and dasabuvir) is an approved treatment for compensated patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection.
This oral regimen has minimal adverse effects and is well tolerated.
Cure rates are 97% in patients infected with HCV GT 1a and 99% in those with HCV GT 1b.
We report the first case of life-threatening allergic pneumonitis associated with VIEKIRA PAK.
This unexpected serious adverse event occurred in a 68-year-old Chinese female with genotype 1b chronic hepatitis C and Child-Pugh A cirrhosis.
One week into treatment with VIEKIRA PAK without ribavirin, she was admitted to hospital with respiratory distress and acute kidney injury requiring intensive care input.
She was initially diagnosed with community acquired pneumonia and improved promptly with intravenous antibiotics and supported care.
No bacterial or viral pathogens were cultured.
Following complete recovery, she recommenced VIEKIRA PAK but represented 5 days later with more rapidly progressive respiratory failure, requiring intubation and ventilation, inotropic support, and haemodialysis.
The final diagnosis was drug induced pneumonitis.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Wu, Shih Yea Sylvia& Faire, Bridget& Gane, Edward. 2017. Drug Induced Pneumonitis Secondary to Treatment with ParitaprevirRitonavirOmbitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction. Case Reports in Medicine،Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1146748
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Wu, Shih Yea Sylvia…[et al.]. Drug Induced Pneumonitis Secondary to Treatment with ParitaprevirRitonavirOmbitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction. Case Reports in Medicine No. 2017 (2017), pp.1-5.
https://search.emarefa.net/detail/BIM-1146748
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Wu, Shih Yea Sylvia& Faire, Bridget& Gane, Edward. Drug Induced Pneumonitis Secondary to Treatment with ParitaprevirRitonavirOmbitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction. Case Reports in Medicine. 2017. Vol. 2017, no. 2017, pp.1-5.
https://search.emarefa.net/detail/BIM-1146748
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1146748
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر